Figure 2

(a) Kaplan-Meier (KM) OS and PFS curves for the whole cohort; (b) KM OS and PFS curves for the whole cohort according to the IRS risk group (low risk vs. intermediate risk); (c) Comparative efficacy of different chemotherapeutic regimens on PFS outcomes; (d) Comparative efficacy of different chemotherapeutic regimens on OS outcomes.